Modern Strategies For Correction Of Metabolic Disorders In Cardiorenal Syndrome
International Journal of Medical Science and Public Health Research · 01.05.2026 · 7 (5) · 37-39
DOI: 10.37547/ijmsphr/volume07issue05-09 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Medical Science and Public Health Research, online erschienen am 01.05.2026. Verfasst von Khudoyberdieva G.A..
Abstract (Originalsprache)
The article examines metabolic disorders such as insulin resistance, hyperglycemia, and dyslipidemia in patients with chronic heart failure (CHF) and chronic kidney disease (CKD). These disorders play a key role in the progression of both diseases. The article analyzes modern therapeutic approaches, including the use of SGLT2 inhibitors and mineralocorticoid receptor antagonists, as well as the importance of personalized therapy.
Zitieren
APA
G.A., K. (2026). Modern Strategies For Correction Of Metabolic Disorders In Cardiorenal Syndrome. International Journal of Medical Science and Public Health Research, 7(5), 37-39. https://doi.org/10.37547/ijmsphr/volume07issue05-09
Vancouver
G.A. K. Modern Strategies For Correction Of Metabolic Disorders In Cardiorenal Syndrome. International Journal of Medical Science and Public Health Research. 2026;7(5):37-39. doi:10.37547/ijmsphr/volume07issue05-09
BibTeX
@article{GA2026,
author = {G.A., Khudoyberdieva},
title = {Modern Strategies For Correction Of Metabolic Disorders In Cardiorenal Syndrome},
journal = {International Journal of Medical Science and Public Health Research},
year = {2026},
volume = {7},
number = {5},
pages = {37--39},
doi = {10.37547/ijmsphr/volume07issue05-09}
}
EUVIMED